论文部分内容阅读
目的为探讨慢性乙型病毒型肝炎的抗病毒治疗效果,本文将苦参素联合单磷酸阿糖腺苷(Ara-AMp)(治疗组)与单用(Ara-AMp)抗病毒治疗慢性乙型病毒性肝炎(对照组)HBVDNA定量变化对比观察。方法治疗组(50例)采用苦参素联合单磷酸阿糖腺苷抗病毒治疗,对照组(56例)采用单磷酸阿糖腺苷抗病毒治疗。两组治疗结果采用χ2检验。结果治疗组HBVDNA阴转率64.0%,HBeAg阴转率58.0%,对照组HBVDNA阴转率39.3%,HBeAg阴转率37.5%。结论苦参素联合单磷酸阿糖腺苷抗病毒治疗优于单用单磷酸阿糖腺苷抗病毒治疗。
Objective To investigate the antiviral effect of chronic hepatitis B virus infection in this paper, the combination of matrine and Ara-AMp (treatment group) and single-use anti-virus (Ara-AMp) Comparison of quantitative changes of HBVDNA in viral hepatitis (control group). Methods The treatment group (50 cases) was treated with oxymatrine combined with oxymatrine and the control group (56 cases) with adenosine monophosphate. Two groups of treatment results using χ2 test. Results In the treatment group, the negative conversion rate of HBVDNA was 64.0%, the negative conversion rate of HBeAg was 58.0%, the negative conversion rate of HBVDNA in control group was 39.3%, and the negative conversion rate of HBeAg was 37.5%. Conclusion The combination of oxymatrine and matrine combined with antiviral therapy is better than that of single-dose adenosine monophosphate therapy.